A multi-center, double-blind, randomized parallel-group Phase IV study comparing the efficacy and safety of thiocolchicoside ointment versus placebo in patients with chronic mechanical low back pain and an acute muscle spasm

Öz:

Objectives: This study aims to evaluate the efficacy and safety of thiocolchicoside (TCC) ointment treatment compared to placebo in patients with chronic mechanical low back pain (LBP) accompanied by acute muscle spasms. Patients and methods: A total of 292 adult patients (106 males, 186 females; mean age: 38.5±11.2 years; range, 18 to 64 years) were randomized to TCC group (n=147) and placebo group (n=145) in 12 centers between March 2020 and March 2021. Eight patients from each group were excluded from the analysis. The primary endpoint was pressure pain threshold (PPT) on Day 3, which was measured using a pressure algometer. Secondary endpoints were PPT on Day 7, patient, and physician Visual Analog Scales-pain (VAS-pain) on Days 3 and 7, and safety. Results: The PPT values on Day 3 was not significantly different between the treatment groups (p=0.701). Similarly, TCC and placebo group had similar VAS-pain scores over trial period (p=0.577 or higher for comparisons). Significantly higher PPT values and lower VAS-pain scores on Days 3 and 7 were observed in both groups (p<0.001 for all). In patients with a PPT value of ≥3.87, TCC arm had higher PPT on Day 3 compared to placebo (p=0.029). Three patients (two in the TCC arm and one in the placebo arm) discontinued the trial due to an adverse event. Conclusion: Topical TCC can be an appropriate option in a subset of patients with mild chronic LBP accompanied by muscle spasms. In a subset of patients with milder pain intensity, topical TCC may improve pain earlier. The results of this trial are compatible with the treatment approaches used in daily practice.

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018;392:1789-858.
2. Walker BF. The prevalence of low back pain: A systematic review of the literature from 1966 to 1998. J Spinal Disord 2000;13:205-17.
3. Hartvigsen J, Hancock MJ, Kongsted A, Louw Q, Ferreira ML, Genevay S, et al. What low back pain is and why we need to pay attention. Lancet 2018;391:2356-67.
4. Pengel LH, Herbert RD, Maher CG, Refshauge KM. Acute low back pain: Systematic review of its prognosis. BMJ 2003;327:323.
5. Patrick N, Emanski E, Knaub MA. Acute and chronic low back pain. Med Clin North Am 2014;98:777-89.
6. Patat A, Klein MJ, Surjus A, Renault M, Rezvani Y, Granier J. Effects of acute and repeated doses of two muscle relaxants chlormezanone and thiocolchicoside, on vigilance and psychomotor performance of healthy volunteers. Hum Psychopharmacol Clin Exp 1991;6:285-92.
7. Janbroers JM. Review of the toxicology, pharmacodynamics and pharmacokinetics of thiocolchicoside, a GABA-agonist muscle relaxant with anti-inflammatory and analgesic actions. Acta Therapeutica 1987;13:221-50.
8. Foster NE, Anema JR, Cherkin D, Chou R, Cohen SP, Gross DP, et al. Prevention and treatment of low back pain: Evidence, challenges, and promising directions. Lancet 2018;391:2368-83.
9. Ketenci A, Zure M. Pharmacological and nonpharmacological treatment approaches to chronic lumbar back pain. Turk J Phys Med Rehabil 2021;67:1-10.
10. Ketenci A, Basat H, Esmaeilzadeh S. The efficacy of topical thiocolchicoside (Muscoril) in the treatment of acute cervical myofascial pain syndrome: A single-blind, randomized, prospective, phase IV clinical study. Agri 2009;21:95-103.
11. van Lennep JHPA, Trossèl F, Perez RSGM, Otten RHJ, van Middendorp H, Evers AWM, et al. Placebo effects in low back pain: A systematic review and meta-analysis of the literature. Eur J Pain 2021;25:1876-97.
12. de Oliveira RF, Liebano RE, Costa Lda C, Rissato LL, Costa LO. Immediate effects of region-specific and nonregion- specific spinal manipulative therapy in patients with chronic low back pain: A randomized controlled trial. Phys Ther 2013;93:748-56.
13. Tüzün F, Unalan H, Oner N, Ozgüzel H, Kirazli Y, Içağasioğlu A, et al. Multicenter, randomized, doubleblinded, placebo-controlled trial of thiocolchicoside in acute low back pain. Joint Bone Spine 2003;70:356-61.
14. Ketenci A, Ozcan E, Karamursel S. Assessment of efficacy and psychomotor performances of thiocolchicoside and tizanidine in patients with acute low back pain. Int J Clin Pract 2005;59:764-70.
15. Aksoy C, Karan A, Dıraçoğlu D. Low back pain: Results of an open clinical trial comparing the standard treatment alone to the combination of standard treatment and thiocolchicoside. J Orthopaed Traumatol 2002;3:103-8.
16. Akhter N, Siddiq MZ. Comparative efficacy of diclofenac sodium alone and in combination with thiocolchicoside in patients with low back pain. Med Forum Mon 2017;28:93-6.
17. Gervasi M, Sisti D, Benelli P, Fernández-Peña E, Calcabrini C, Rocchi MBL, et al. The effect of topical thiocolchicoside in preventing and reducing the increase of muscle tone, stiffness, and soreness: A real-life study on top-level road cyclists during stage competition. Medicine (Baltimore) 2017;96:e7659.
18. Altan L, Kasapoğlu Aksoy M, Kösegil Öztürk E. Efficacy of diclofenac & thiocolchioside gel phonophoresis comparison with ultrasound therapy on acute low back pain; a prospective, double-blind, randomized clinical study. Ultrasonics 2019;91:201-5.
19. Giesbrecht RJ, Battié MC. A comparison of pressure pain detection thresholds in people with chronic low back pain and volunteers without pain. Phys Ther 2005;85:1085-92.
20. Granges G, Littlejohn G. Pressure pain threshold in pain-free subjects, in patients with chronic regional pain syndromes, and in patients with fibromyalgia syndrome. Arthritis Rheum 1993;36:642-6.
21. Imamura M, Chen J, Matsubayashi SR, Targino RA, Alfieri FM, Bueno DK, et al. Changes in pressure pain threshold in patients with chronic nonspecific low back pain. Spine (Phila Pa 1976) 2013;38:2098-107.
22. European Medicines Agency (EMA) recommendation. Available at: https://www.ema.europa.eu/en/documents/ referral/article-31-referral-european-medicines-agencyrecommends- restricting-use-thiocolchicoside-mouth_ en.pdf [Access: August 22, 2021].
23. Patrick N, Emanski E, Knaub MA. Acute and chronic low back pain. Med Clin North Am 2016;100:169-81.
24. Parthan A, Evans CJ, Le K. Chronic low back pain: Epidemiology, economic burden and patient-reported outcomes in the USA. Expert Rev Pharmacoecon Outcomes Res 2006;6:359-69.
25. Walker BF, Muller R, Grant WD. Low back pain in Australian adults: The economic burden. Asia Pac J Public Health 2003;15:79-87.
26. Maetzel A, Li L. The economic burden of low back pain: A review of studies published between 1996 and 2001. Best Pract Res Clin Rheumatol 2002;16:23-30.
27. Stewart WF, Ricci JA, Chee E, Morganstein D, Lipton R. Lost productive time and cost due to common pain conditions in the US workforce. JAMA 2003;290:2443-54.

APA	Ketenci A, Sindel D, Koca T, karahan a, ERDAL A, AYDIN E, Sarifakioglu B, USTAÖMER K, Talay Çalış H, Sarıkaya S, SARI İ, celik c, Dilek B, AKALIN E, Coskun Benlidayi I, Guzel R (2022). A multi-center, double-blind, randomized parallel-group Phase IV study comparing the efficacy and safety of thiocolchicoside ointment versus placebo in patients with chronic mechanical low back pain and an acute muscle spasm. , 456 - 463. 10.5606/tftrd.2022.9744
Chicago	Ketenci Ayşegül,Sindel Dilsad,Koca Tuba Tülay,karahan ali yavuz,ERDAL AKIN,AYDIN ELIF,Sarifakioglu Banu,USTAÖMER KÜBRA,Talay Çalış Havva,Sarıkaya Selda,SARI İLKER FATİH,celik canan,Dilek Banu,AKALIN ELIF,Coskun Benlidayi Ilke,Guzel Rengin A multi-center, double-blind, randomized parallel-group Phase IV study comparing the efficacy and safety of thiocolchicoside ointment versus placebo in patients with chronic mechanical low back pain and an acute muscle spasm. (2022): 456 - 463. 10.5606/tftrd.2022.9744
MLA	Ketenci Ayşegül,Sindel Dilsad,Koca Tuba Tülay,karahan ali yavuz,ERDAL AKIN,AYDIN ELIF,Sarifakioglu Banu,USTAÖMER KÜBRA,Talay Çalış Havva,Sarıkaya Selda,SARI İLKER FATİH,celik canan,Dilek Banu,AKALIN ELIF,Coskun Benlidayi Ilke,Guzel Rengin A multi-center, double-blind, randomized parallel-group Phase IV study comparing the efficacy and safety of thiocolchicoside ointment versus placebo in patients with chronic mechanical low back pain and an acute muscle spasm. , 2022, ss.456 - 463. 10.5606/tftrd.2022.9744
AMA	Ketenci A,Sindel D,Koca T,karahan a,ERDAL A,AYDIN E,Sarifakioglu B,USTAÖMER K,Talay Çalış H,Sarıkaya S,SARI İ,celik c,Dilek B,AKALIN E,Coskun Benlidayi I,Guzel R A multi-center, double-blind, randomized parallel-group Phase IV study comparing the efficacy and safety of thiocolchicoside ointment versus placebo in patients with chronic mechanical low back pain and an acute muscle spasm. . 2022; 456 - 463. 10.5606/tftrd.2022.9744
Vancouver	Ketenci A,Sindel D,Koca T,karahan a,ERDAL A,AYDIN E,Sarifakioglu B,USTAÖMER K,Talay Çalış H,Sarıkaya S,SARI İ,celik c,Dilek B,AKALIN E,Coskun Benlidayi I,Guzel R A multi-center, double-blind, randomized parallel-group Phase IV study comparing the efficacy and safety of thiocolchicoside ointment versus placebo in patients with chronic mechanical low back pain and an acute muscle spasm. . 2022; 456 - 463. 10.5606/tftrd.2022.9744
IEEE	Ketenci A,Sindel D,Koca T,karahan a,ERDAL A,AYDIN E,Sarifakioglu B,USTAÖMER K,Talay Çalış H,Sarıkaya S,SARI İ,celik c,Dilek B,AKALIN E,Coskun Benlidayi I,Guzel R "A multi-center, double-blind, randomized parallel-group Phase IV study comparing the efficacy and safety of thiocolchicoside ointment versus placebo in patients with chronic mechanical low back pain and an acute muscle spasm." , ss.456 - 463, 2022. 10.5606/tftrd.2022.9744
ISNAD	Ketenci, Ayşegül vd. "A multi-center, double-blind, randomized parallel-group Phase IV study comparing the efficacy and safety of thiocolchicoside ointment versus placebo in patients with chronic mechanical low back pain and an acute muscle spasm". (2022), 456-463. https://doi.org/10.5606/tftrd.2022.9744

APA	Ketenci A, Sindel D, Koca T, karahan a, ERDAL A, AYDIN E, Sarifakioglu B, USTAÖMER K, Talay Çalış H, Sarıkaya S, SARI İ, celik c, Dilek B, AKALIN E, Coskun Benlidayi I, Guzel R (2022). A multi-center, double-blind, randomized parallel-group Phase IV study comparing the efficacy and safety of thiocolchicoside ointment versus placebo in patients with chronic mechanical low back pain and an acute muscle spasm. Turkish Journal of Physical Medicine and Rehabilitation, 68(4), 456 - 463. 10.5606/tftrd.2022.9744
Chicago	Ketenci Ayşegül,Sindel Dilsad,Koca Tuba Tülay,karahan ali yavuz,ERDAL AKIN,AYDIN ELIF,Sarifakioglu Banu,USTAÖMER KÜBRA,Talay Çalış Havva,Sarıkaya Selda,SARI İLKER FATİH,celik canan,Dilek Banu,AKALIN ELIF,Coskun Benlidayi Ilke,Guzel Rengin A multi-center, double-blind, randomized parallel-group Phase IV study comparing the efficacy and safety of thiocolchicoside ointment versus placebo in patients with chronic mechanical low back pain and an acute muscle spasm. Turkish Journal of Physical Medicine and Rehabilitation 68, no.4 (2022): 456 - 463. 10.5606/tftrd.2022.9744
MLA	Ketenci Ayşegül,Sindel Dilsad,Koca Tuba Tülay,karahan ali yavuz,ERDAL AKIN,AYDIN ELIF,Sarifakioglu Banu,USTAÖMER KÜBRA,Talay Çalış Havva,Sarıkaya Selda,SARI İLKER FATİH,celik canan,Dilek Banu,AKALIN ELIF,Coskun Benlidayi Ilke,Guzel Rengin A multi-center, double-blind, randomized parallel-group Phase IV study comparing the efficacy and safety of thiocolchicoside ointment versus placebo in patients with chronic mechanical low back pain and an acute muscle spasm. Turkish Journal of Physical Medicine and Rehabilitation, vol.68, no.4, 2022, ss.456 - 463. 10.5606/tftrd.2022.9744
AMA	Ketenci A,Sindel D,Koca T,karahan a,ERDAL A,AYDIN E,Sarifakioglu B,USTAÖMER K,Talay Çalış H,Sarıkaya S,SARI İ,celik c,Dilek B,AKALIN E,Coskun Benlidayi I,Guzel R A multi-center, double-blind, randomized parallel-group Phase IV study comparing the efficacy and safety of thiocolchicoside ointment versus placebo in patients with chronic mechanical low back pain and an acute muscle spasm. Turkish Journal of Physical Medicine and Rehabilitation. 2022; 68(4): 456 - 463. 10.5606/tftrd.2022.9744
Vancouver	Ketenci A,Sindel D,Koca T,karahan a,ERDAL A,AYDIN E,Sarifakioglu B,USTAÖMER K,Talay Çalış H,Sarıkaya S,SARI İ,celik c,Dilek B,AKALIN E,Coskun Benlidayi I,Guzel R A multi-center, double-blind, randomized parallel-group Phase IV study comparing the efficacy and safety of thiocolchicoside ointment versus placebo in patients with chronic mechanical low back pain and an acute muscle spasm. Turkish Journal of Physical Medicine and Rehabilitation. 2022; 68(4): 456 - 463. 10.5606/tftrd.2022.9744
IEEE	Ketenci A,Sindel D,Koca T,karahan a,ERDAL A,AYDIN E,Sarifakioglu B,USTAÖMER K,Talay Çalış H,Sarıkaya S,SARI İ,celik c,Dilek B,AKALIN E,Coskun Benlidayi I,Guzel R "A multi-center, double-blind, randomized parallel-group Phase IV study comparing the efficacy and safety of thiocolchicoside ointment versus placebo in patients with chronic mechanical low back pain and an acute muscle spasm." Turkish Journal of Physical Medicine and Rehabilitation, 68, ss.456 - 463, 2022. 10.5606/tftrd.2022.9744
ISNAD	Ketenci, Ayşegül vd. "A multi-center, double-blind, randomized parallel-group Phase IV study comparing the efficacy and safety of thiocolchicoside ointment versus placebo in patients with chronic mechanical low back pain and an acute muscle spasm". Turkish Journal of Physical Medicine and Rehabilitation 68/4 (2022), 456-463. https://doi.org/10.5606/tftrd.2022.9744